These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 35834269)
1. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China. Qiao H; Tan XR; Li H; Li JY; Chen XZ; Li YQ; Li WF; Tang LL; Zhou GQ; Zhang Y; Liang YL; He QM; Zhao Y; Huang SY; Gong S; Li Q; Ye ML; Chen KL; Sun Y; Ma J; Liu N JAMA Oncol; 2022 Sep; 8(9):1301-1309. PubMed ID: 35834269 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165 [TBL] [Abstract][Full Text] [Related]
3. Synergistic Association of Hepatitis B Surface Antigen and Plasma Epstein-Barr Virus DNA Load on Distant Metastasis in Patients With Nasopharyngeal Carcinoma. Li H; Cao D; Li S; Chen B; Zhang Y; Zhu Y; Luo C; Lin W; Huang W; Ruan G; Zhang R; Li J; Liu L JAMA Netw Open; 2023 Feb; 6(2):e2253832. PubMed ID: 36757699 [TBL] [Abstract][Full Text] [Related]
4. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection. Liu YP; Li H; You R; Li JB; Liu XK; Yang AK; Guo X; Song M; Zhang Q; Guo ZM; Chen WK; Liu WW; Zou X; Hua YJ; Yang Q; Zhang YN; Sun R; Mo HY; Guo L; Lin AH; Mai HQ; Qian CN; Chen MY Laryngoscope; 2019 Feb; 129(2):387-395. PubMed ID: 30325027 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814 [TBL] [Abstract][Full Text] [Related]
6. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma. Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539 [TBL] [Abstract][Full Text] [Related]
7. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system]. Mao YP; Hong MH; Sun Y; Liang SB; Li L; Liu LZ; Tang LL; Cao SM; Lin AH; Lu TX; Liu MZ; Ma J Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881 [TBL] [Abstract][Full Text] [Related]
8. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients. Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383 [TBL] [Abstract][Full Text] [Related]
9. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma. Zhang LL; Huang MY; Li Y; Liang JH; Gao TS; Deng B; Yao JJ; Lin L; Chen FP; Huang XD; Kou J; Li CF; Xie CM; Lu Y; Sun Y EBioMedicine; 2019 Apr; 42():270-280. PubMed ID: 30928358 [TBL] [Abstract][Full Text] [Related]
10. Geographical disparities in the prognosis of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a large institution-based cohort study from an endemic area. Lin ST; Meng DF; Yang Q; Wang W; Peng LX; Zheng LS; Qiang YY; Mei Y; Xu L; Li CZ; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Li HF; Huang BJ; Qian CN; Sun R BMJ Open; 2020 Nov; 10(11):e037150. PubMed ID: 33172940 [TBL] [Abstract][Full Text] [Related]
11. Intratumoral microbiota associates with systemic immune inflammation state in nasopharyngeal carcinoma. Zhang Q; Song J; Wu H; Wang L; Zhuo G; Li H; He S; Pan Y; Liu G Int Immunopharmacol; 2024 Nov; 141():112984. PubMed ID: 39173404 [TBL] [Abstract][Full Text] [Related]
12. Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020. Liang YJ; Liu LT; Li Y; Wang P; Luo MJ; Wen DX; Chen QY; Mai HQ JAMA Netw Open; 2022 Mar; 5(3):e220173. PubMed ID: 35234882 [TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study. Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117 [TBL] [Abstract][Full Text] [Related]
14. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma. Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116 [TBL] [Abstract][Full Text] [Related]
15. Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma. Li WZ; Wu HJ; Lv SH; Hu XF; Liang H; Liu GY; Lu N; Bei WX; Lv X; Guo X; Xia WX; Xiang YQ JAMA Netw Open; 2021 Sep; 4(9):e2124721. PubMed ID: 34554238 [TBL] [Abstract][Full Text] [Related]
16. Long-term Therapeutic Outcome and Prognostic Factors of Patients with Nasopharyngeal Carcinoma Receiving Intensity-modulated Radiotherapy: An Analysis of 608 Patients from Low-endemic Regions of China. Huang J; Yang ZY; Wu B; Ding Q; Qin Y; Zhang ZJ; Yin ZY; Liang ZW; Han J; Wang Y; Peng ZJ; Peng G; Li Q; Wu G; Yang KY Curr Med Sci; 2021 Aug; 41(4):737-745. PubMed ID: 34403099 [TBL] [Abstract][Full Text] [Related]
17. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma. Deng YF; Zhou DN; Pan ZY; Yin P Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956 [TBL] [Abstract][Full Text] [Related]
18. [A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma]. Mao YP; Li WF; Chen L; Sun Y; Liu LZ; Tang LL; Cao SM; Lin AH; Hong MH; Lu TX; Liu MZ; Li L; Ma J Ai Zheng; 2009 Oct; 28(10):1022-8. PubMed ID: 19799808 [TBL] [Abstract][Full Text] [Related]
19. [The role of retropharyngeal lymph node metastasis in staging of nasopharyngeal carcinoma]. Tang LL; Liu LZ; Ma J; Zong JF; Huang Y; Lin AH; Lu TX; Cui NJ Ai Zheng; 2006 Feb; 25(2):129-35. PubMed ID: 16480573 [TBL] [Abstract][Full Text] [Related]
20. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma. Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]